HCC Prevention & Diagnosis Country Data

We have developed an interactive data map to view and compare liver cancer information from across Europe. Click on a country to see the available data.

image/svg+xml
Austria
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is 45-65%
  • Percentage of pregnant women screened for HBV around 65%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination 65-85%
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government and patient organisations.
  • HCV treatment is accessible and the first round of treatment is reimbursed
Awareness campaigns…
  • about liver disease exist, organised by government
  • about the benefits of HBV vaccination exist, organised by government and medical societies
Awareness level about HCC…
  • risk factors, of the general public is very poor
  • risk factors, of primary care physicians is poor
  • signs and symptoms, of at-risk populations is very poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is very poor
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, organised by government
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
  • There is stigma associated with HBV infection, HCV infection, liver disease and HCC
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, adherence is 100%
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s)
Diagnosis stage
  • Early stage (stage A)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 2 weeks
  • After initial referral diagnostic investigations are usually completed within 2-3 months
  • After staging and diagnosis treatment usually starts within 2-3 months
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
    N/A
Belgium
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is abover 95%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is above 95%
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government.
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about liver cancer exist, organised by charities/patient organisations
  • about the benefits of HBV vaccination do not exist
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is poor
  • signs and symptoms, of at-risk populations is poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is poor
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome do not exist
  • Official organised efforts to control the accessibility and popularity of alcohol consumption do not exist
Stigma
    N/A
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, adherence is 50-75%
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s) and no recall system
Diagnosis stage
  • Intermediate stage (stage B)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 4 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
    N/A
Bulgaria
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is above 95%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is above 95%
  • Not known if official organised efforts to vaccinate affected adult populations against HBV
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis exist, organised by medical societies
  • about the benefits of HBV vaccination exist, organised by medical societies
Awareness level about HCC…
  • risk factors, of the general public is very poor
  • risk factors, of primary care physicians is very poor
  • signs and symptoms, of at-risk populations is moderate
  • signs and symptoms, of the general public is moderate
  • signs and symptoms, of primary care physicians is moderate
Prevention efforts
  • Not known if official organised efforts to prevent people from developing metabolic syndrome
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
    N/A
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, adherence is around 50%
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed less frequently than once a year, not known what nonadherence to surveillance most likely due to
Diagnosis stage
  • Advanced stage (stage C)
Timings related to diagnosis
  • Not known how soon after a GP referral patients are seen by a specialist doctor
  • Not known how soon after initial referral diagnostic investigations are usually completed
  • After staging and diagnosis treatment usually starts within 2 weeks
Multidisciplinary approach
  • Not known if diagnosis and staging of HCC managed by a multidisciplinary medical team
  • Initial treatment plan after diagnosis is always designed and discussed by a multidisciplinary medical team
Incidence and prevalence data
    N/A
Croatia
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is around 95%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is 85-95%
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government, patient organisations, non-governekmental organisations
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about liver disease, hepatitis and liver cancer exist, organised by government, medical societies, charities/patient organisations
  • about the benefits of HBV vaccination exist, organised by medical societies, government, charities/patient organisations
Awareness level about HCC…
  • risk factors, of the general public is poor-moderate
  • risk factors, of primary care physicians is poor
  • signs and symptoms, of at-risk populations is poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, organised by government, patient organisations, non-governmental institutions
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government, patient organisations, non-governmental institutions
Stigma
  • There is stigma associated with HBV infection, HCV infection, liver disease and HCC
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, adherence is around 50%
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed every 6 months, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s), patients not attending appointments and no recall system
Diagnosis stage
  • Advanced stage (stage C)/Intermediate stage (stage B)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 4 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
  • HBV prevalence 0.2-0.7 %, incidence 100 cases per year (on 3.8 mil. population), source Croatian Institute of Public Health, 2023.
  • HCV prevalence 0.5-0.9 %, incidence 150-200 cases per year (on 3.8 mil. population), source Croatian Institute of Public Health, 2023.
  • HCC prevalence 8.5%, incidence 400 cases per year (on 3.8 mil. population), 480 people died of HCC in 2022.; The Report on Causes of Death for 2022. by National Institute for Public Health, published January 16 2024.
Cyprus
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is 85-95%
  • Percentage of pregnant women screened for HBV is not known.
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is not known.
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis, liver disease and liver cancer exist, organised by medical societies
  • about the benefits of HBV vaccination exist, organised by ,government, charities/patient organisations
Awareness level about HCC…
  • risk factors, of the general public is moderate
  • risk factors, of primary care physicians is good
  • signs and symptoms, of at-risk populations is poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is good
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, organised by government, patient organisations, non-governmental institutions
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
  • There is stigma associated with HBV infection, HCV infection, but not with liver disease and HCC
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC do not exist
  • No data on frequency of HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis). Nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s) and no recall system
Diagnosis stage
  • Terminal stage (stage D)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 2-3 months
  • After initial referral diagnostic investigations are usually completed within 4-6 months
  • After staging and diagnosis treatment usually starts within 4-6 months
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
    N/A
Czech Republic
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is above 95%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is above 95%
  • Not known if official organised efforts to vaccinate affected adult populations against HBV exist.
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about liver cancer, hepatitis, liver disease exist, organised by charities/patient organisations, government, pharmaceutical industry, medical societies
  • about the benefits of HBV vaccination not known
Awareness level about HCC…
  • risk factors, of the general public is moderate
  • risk factors, of primary care physicians is very poor
  • signs and symptoms, of at-risk populations is poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is poor
Prevention efforts
  • Not known if official organised efforts to prevent people from developing metabolic syndrome exist
  • Official organised efforts to control the accessibility and popularity of alcohol consumption do not exist
Stigma
  • There is stigma associated with HBV infection, HCV infection, liver disease but not with HCC
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC do not exist
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s), patients not attending appointments and no recall system
Diagnosis stage
  • Intermediate stage (stage B)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 2 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
    N/A
Denmark
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is less than 45%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is not known
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government and patient organisations
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about liver cancer, hepatitis, liver disease and HBV vaccination do not exist
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is good
  • signs and symptoms, of at-risk populations is very poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome do not exist
  • Official organised efforts to control the accessibility and popularity of alcohol consumption do not exist
Stigma
  • There is stigma associated with HCV infection, liver disease but not with HBV infection and HCC.
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, adherence is 50-75%
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to patients not attending appointments
Diagnosis stage
    N/A
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 2 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC is always managed by a multidisciplinary medical team
  • Initial treatment plan after diagnosis is always designed and discussed by a multidisciplinary medical team
Incidence and prevalence data
    N/A
Finland
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • No data on coverage (3rd dose) for childhood HBV vaccination
  • No data on percentage of pregnant women screened for HBV
  • No data on percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination
  • Official organised efforts to vaccinate affected adult populations against HBV do not exist
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis exist, organised by government, charities/patient organisations, medical societies
  • about the benefits of HBV vaccination do not exist
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is good
  • signs and symptoms, of at-risk populations is moderate
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is very good
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, by government and non-governmental institutions
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
  • There is stigma associated with HCV infection, HBV infection, no data on liver disease and HCC.
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, no data on adherence
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s), patients not attending appointments
Diagnosis stage
  • Advanced stage (stage C)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 2 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 2 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC is always managed by a multidisciplinary medical team
  • Initial treatment plan after diagnosis is always designed and discussed by a multidisciplinary medical team
Incidence and prevalence data
  • HBV prevalence: Acute: 0,07/100 000, Chronic: 2,89/100 000 (source) “25,000–30,000 carriers of HCV (0.5% of the population)” 12.7.2021 Duodecim
France
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination not known
  • Percentage of pregnant women screened for HBV not known
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is not known
  • Not known if official organised efforts to vaccinate affected adult populations against HBV exist
  • Not known if HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis and HBV vaccination exist, organised by government
Awareness level about HCC…
  • risk factors, of the general public is poor-moderate
  • risk factors, of primary care physicians is poor
  • signs and symptoms, of at-risk populations is very poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, organised by government
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
  • No stigma associated with HCV infection, liver disease, HBV infection and HCC.
HCC surveillance
  • Not known if county-specific guidelines that recommend the surveillance of HCC exist
  • Not known hlow frequently HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s)
Diagnosis stage
    N/A
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor after 6 months
  • After initial referral diagnostic investigations are usually completed within 4-6 months
  • After staging and diagnosis treatment usually starts within 2-3 months
Multidisciplinary approach
  • Diagnosis and staging of HCC is sometimes managed by a multidisciplinary medical team
  • Not known if initial treatment plan after diagnosis is designed and discussed by a multidisciplinary medical team
Incidence and prevalence data
    N/A
Germany
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
    N/A
Awareness campaigns…
    N/A
Awareness level about HCC…
    N/A
Prevention efforts
    N/A
Stigma
    N/A
HCC surveillance
    N/A
Diagnosis stage
    N/A
Timings related to diagnosis
    N/A
Multidisciplinary approach
    N/A
Incidence and prevalence data
    N/A
Greece
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is 65-85%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is 65-85%
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about liver disease and HBV vaccination exist, organised by medical societies
Awareness level about HCC…
  • risk factors, of the general public is moderate
  • risk factors, of primary care physicians is poor
  • signs and symptoms, of at-risk populations is moderate
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome do not exist
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist organised by government
Stigma
  • No stigma associated with HCV infection, liver disease, HBV infection and HCC.
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC do not exist
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to patients not attending appointments
Diagnosis stage
  • Intermediate stage (stage B)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 2-3 months
  • After staging and diagnosis treatment usually starts within 4 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
    N/A
Hungary
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is above 95%
  • Percentage of pregnant women screened for HBV is above 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is not known
  • Not known if official organised efforts to vaccinate affected adult populations against HBV exist
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
    N/A
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is good
  • signs and symptoms, of at-risk populations is very poor
  • signs and symptoms, of the general public is very poor
  • signs and symptoms, of primary care physicians is good
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, orgnaised by government
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
  • Not known if there is stigma associated with HCV infection, liver disease, HBV infection and HCC.
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist. Adherence unknown.
  • Frequency of HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is not known, not known what, nonadherence to surveillance is most likely due to.
Diagnosis stage
    N/A
Timings related to diagnosis
  • Not known how soon after a GP referral are patients seen by a specialist doctor.
  • Not known how soon after initial referral diagnostic investigations are usually completed.
  • Not known how soon after staging and diagnosis treatment starts.
Multidisciplinary approach
  • Diagnosis and staging of HCC is always managed by a multidisciplinary medical team
  • Initial treatment plan after diagnosis is always designed and discussed by a multidisciplinary medical team
Incidence and prevalence data
Ireland
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
    N/A
Awareness campaigns…
    N/A
Awareness level about HCC…
    N/A
Prevention efforts
    N/A
Stigma
    N/A
HCC surveillance
    N/A
Diagnosis stage
    N/A
Timings related to diagnosis
    N/A
Multidisciplinary approach
    N/A
Incidence and prevalence data
    N/A
Italy
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is around 85%
  • Percentage of pregnant women screened for HBV is around 85%.
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is above 95%.
  • Official organised efforts to vaccinate affected adult populations against HBV exist, organised by government
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis and liver disease exist, organised by government, charities/patient organisations, medical societies
  • about the benefits of HBV vaccination exist, organised by government, charities/patient organisations
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is poor-moderate
  • signs and symptoms, of at-risk populations is poor-moderate
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is poor-moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, organised by government, non-governmental insitutions
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government, non-governmental insitutions
Stigma
  • There is stigma associated with HBV infection, HCV infection, liver disease and possibly less with HCC (50% answered yes)
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC exist, adherence is 50-75%
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is carried out every 6 months or more frequently, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s), patients not attending appointments and no recall system
Diagnosis stage
  • Early (stage A) to Intermediate stage (stage B)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 4 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC managed by a multidisciplinary medical team most of the time
  • Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
  • HBV incidence: 153 cases/year (Source: Italian institute of health - epidemiology for public health)
  • HCV Incidence: 51 cases/year (Source: Italian institute of health - epidemiology for public health)
  • The average annual incidence rates of HCC per 100,000 persons were 14.6 (men) and 3.5 (women) (Source: The Italian Cancer Registries'
  • Collaborative Group. Cancers (Basel). 2022 Dec 14;14(24):6162. doi: 10.3390/cancers14246162.); HCC mortality rate 7% (data: AIOM)
Latvia
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is 85-95%
  • Percentage of pregnant women screened for HBV is around 95%.
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is around 95%.
  • Official organised efforts to vaccinate affected adult populations against HBV do not exist
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis, liver cancer and liver disease exist, organised by government, charities/patient organisations, medical societies about the benefits of HBV vaccination do not exist
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is moderate
  • signs and symptoms, of at-risk populations is poor-moderate
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist, organised by government, non-governmental insitutions
  • Official organised efforts to control the accessibility and popularity of alcohol consumption exist, organised by government
Stigma
  • There may be stigma associated with HBV infection and HCV infection (50% answered yes) but not with liver disease and HCC
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC do not exist
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is carried out every 6 months,, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s), patients not attending appointments and no recall system
Diagnosis stage
  • Advanced stage (stage C)
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 2-4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • After staging and diagnosis treatment usually starts within 4 weeks
Multidisciplinary approach
  • Diagnosis and staging of HCC is almost always managed by a multidisciplinary medical team Initial treatment plan after diagnosis designed and discussed by a multidisciplinary medical team most of the time
Incidence and prevalence data
Lithuania
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is 85-95%
  • Percentage of pregnant women screened for HBV is 85-95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is 85-95%
  • Official organised efforts to vaccinate affected adult populations against HBV do not exist
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about hepatitis exist, organised by medical societies
  • about the benefits of HCV vaccination do not exist
Awareness level about HCC…
  • risk factors, of the general public is poor
  • risk factors, of primary care physicians is poor
  • signs and symptoms, of at-risk populations is poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is poor
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome do not exist
  • Official organised efforts to control the accessibility and popularity of alcohol consumption do not exist
Stigma
  • There is stigma associated with HCV infection, HBV infection, liver disease. Not known for HCC.
HCC surveillance
  • County-specific guidelines that recommend the surveillance of HCC do not exist.
  • HCC surveillance in patients for whom surveillance is recommended (eg. patients with liver cirrhosis) is performed 6 months or more frequently, nonadherence to surveillance most likely due to clinicians not referring patients to screening test(s), patients not attending appointments and no recall system
Diagnosis stage
    N/A
Timings related to diagnosis
  • After a GP referral patients seen by a specialist doctor within 4 weeks
  • After initial referral diagnostic investigations are usually completed within 4 weeks
  • Not known how soon after staging and diagnosis treatment usually starts
Multidisciplinary approach
  • Diagnosis and staging of HCC is always managed by a multidisciplinary medical team
  • Initial treatment plan after diagnosis is always designed and discussed by a multidisciplinary medical team
Incidence and prevalence data
    N/A
Netherlands
Hepatitis B and C (HBV and HCV) Prevention, Diagnosis, Treatment
  • Coverage (3rd dose) for childhood HBV vaccination is around 85%
  • Percentage of pregnant women screened for HBV is around 95%
  • Percentage of new-borns receiving timely (within 24 hours of birth) HBV birth-dose vaccination is above 95%
  • Not known if official organised efforts to vaccinate affected adult populations against HBV exist.
  • HCV treatment is accessible and reimbursed
Awareness campaigns…
  • about liver cancer and hepatitis exist, organised by charities/patient organisations, government, pharmaceutical industry, medical societies about the benefits of HBV vaccination exist, organised by government, charities/patient organisations
Awareness level about HCC…
  • risk factors, of the general public is very poor-poor
  • risk factors, of primary care physicians is moderate
  • signs and symptoms, of at-risk populations is poor
  • signs and symptoms, of the general public is poor
  • signs and symptoms, of primary care physicians is poor-moderate
Prevention efforts
  • Official organised efforts to prevent people from developing metabolic syndrome exist org